NPs Basic Information

Name
4-Hydroxy-1-methyl-2-quinolone
Molecular Formula C10H9NO2
IUPAC Name*
4-hydroxy-1-methylquinolin-2-one
SMILES
CN1C2=CC=CC=C2C(=CC1=O)O
InChI
InChI=1S/C10H9NO2/c1-11-8-5-3-2-4-7(8)9(12)6-10(11)13/h2-6,12H,1H3
InChIKey
RTNPPPQVXREFKX-UHFFFAOYSA-N
Synonyms
4-Hydroxy-1-methyl-2-quinolone; 1677-46-9; 4-Hydroxy-1-methyl-2(1H)-quinolone; 4-hydroxy-1-methylquinolin-2(1H)-one; 4-Hydroxy-1-methylcarbostyril; 1-Methyl-4-hydroxycarbostyril; 2(1H)-Quinolinone, 4-hydroxy-1-methyl-; 4-Hydroxy-N-methylcarbostyril; 4-Hydroxy-1-methyl-2(1H)-quinolinone; CARBOSTYRIL, 4-HYDROXY-1-METHYL-; 1-Methyl-4-hydroxy-2-chinolon; 4-hydroxy-1-methylquinolin-2-one; N-Methyl-4-hydroxykarbostyril; 1-Methyl-4-hydroxy-2-chinolinon; NSC 39973; NSC39973; N-Methyl-4-hydroxykarbostyril [Czech]; 1-Methyl-4-hydroxy-2-chinolon [Czech]; V713CAW761; MFCD00024052; NSC-39973; 1-methyl-4-hydroxy-2(1H)-quinolinone; 4-HYDROXY-1-METHYL-1H-2-QUINOLINONE; N-Methyl-4-hydroxykarbostyril (CZECH); 1-Methyl-4-hydroxy-2-chinolon (CZECH); 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one; EINECS 216-830-3; 4-Hydroxy-1-methyl-1H-quinolin-2-one; 4-HYDROXY-N-METHYL-2-QUINOLONE; BRN 1528990; 1-Methyl-4-hydroxy-2-chinolinon [Czech]; 2(1H)-Quinolinone,4-hydroxy-1-methyl-; Maybridge1_002182; Oprea1_834130; 5-21-12-00311 (Beilstein Handbook Reference); SCHEMBL835056; UNII-V713CAW761; 4-Hydroxy-1-methyl carbostyril; CHEMBL2022051; DTXSID0061874; SCHEMBL13143143; 1-methyl-4-hydroxy-2-quinolone; HMS547L04; WLN: T66 BNVJ B1 EQ; n-methyl-4-hydroxy-2-quinolinone; 4-hydroxy-1-methyl-2-quinolinone; 4-hydroxy-1-methyl-quinolin-2-one; ALBB-019832; BBL036914; STK327478; STL514059; ZINC18190627; AKOS000121455; AKOS037491726; ZINC103644054; SDCCGMLS-0065887.P001; 1-methyl-4-hydroxyquinolin-2(1H)-one; 2-hydroxy-1-methylquinolin-4(1H)-one; N-METHYL-4-HYDROXYQUINOL-2-ONE; UPCMLD0ENAT5889157:001; 1-METHYL-4-HYDROXYQUINOLIN-2-ONE; 4-HYDROXY-N-METHYL-2-QUINOLINONE; NS-01441; DB-043712; CS-0131691; EU-0087440; FT-0618613; M1009; 4-Hydroxy-1-methyl-2(1H)-quinolone, 98%; 4-HYDROXY-1-METHYLQUINOLINE-2(1H)-ONE; AB00694265-02; A810900; W-109693; 1-METHYL-2-OXO-1,2-DIHYDRO-4-HYDROXYQUINOLINE
CAS 1677-46-9
PubChem CID 54686436
ChEMBL ID CHEMBL2022051
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Quinolines and derivative
        • Subclass: Quinolones and derivative
          • Direct Parent: Hydroxyquinolones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 175.18 ALogp: 0.9
HBD: 1 HBA: 2
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 40.5 Aromatic Rings: 2
Heavy Atoms: 13 QED Weighted: 0.662

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.763 MDCK Permeability: 0.00002330
Pgp-inhibitor: 0.001 Pgp-substrate: 0.011
Human Intestinal Absorption (HIA): 0.006 20% Bioavailability (F20%): 0.013
30% Bioavailability (F30%): 0.005

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.905 Plasma Protein Binding (PPB): 83.44%
Volume Distribution (VD): 0.858 Fu: 10.49%

ADMET: Metabolism

CYP1A2-inhibitor: 0.961 CYP1A2-substrate: 0.936
CYP2C19-inhibitor: 0.185 CYP2C19-substrate: 0.542
CYP2C9-inhibitor: 0.076 CYP2C9-substrate: 0.813
CYP2D6-inhibitor: 0.034 CYP2D6-substrate: 0.821
CYP3A4-inhibitor: 0.037 CYP3A4-substrate: 0.25

ADMET: Excretion

Clearance (CL): 8.65 Half-life (T1/2): 0.642

ADMET: Toxicity

hERG Blockers: 0.012 Human Hepatotoxicity (H-HT): 0.089
Drug-inuced Liver Injury (DILI): 0.11 AMES Toxicity: 0.792
Rat Oral Acute Toxicity: 0.076 Maximum Recommended Daily Dose: 0.322
Skin Sensitization: 0.625 Carcinogencity: 0.851
Eye Corrosion: 0.044 Eye Irritation: 0.959
Respiratory Toxicity: 0.799
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002806 0.522 D06GKN 0.356
ENC002158 0.431 D0K7WK 0.356
ENC001042 0.407 D07HBX 0.340
ENC004686 0.394 D06BYV 0.339
ENC004693 0.394 D02WCI 0.333
ENC004684 0.382 D03GET 0.333
ENC002793 0.382 D08EOD 0.328
ENC000028 0.381 D06DLI 0.327
ENC002566 0.379 D06IXT 0.323
ENC001367 0.377 D0B1FE 0.317
*Note: the compound similarity was calculated by RDKIT.